1. Home
  2. TVTX vs OPRA Comparison

TVTX vs OPRA Comparison

Compare TVTX & OPRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TVTX
  • OPRA
  • Stock Information
  • Founded
  • TVTX 2008
  • OPRA 1996
  • Country
  • TVTX United States
  • OPRA Norway
  • Employees
  • TVTX N/A
  • OPRA N/A
  • Industry
  • TVTX Biotechnology: Pharmaceutical Preparations
  • OPRA Computer Software: Prepackaged Software
  • Sector
  • TVTX Health Care
  • OPRA Technology
  • Exchange
  • TVTX Nasdaq
  • OPRA Nasdaq
  • Market Cap
  • TVTX 1.4B
  • OPRA 1.6B
  • IPO Year
  • TVTX N/A
  • OPRA 2018
  • Fundamental
  • Price
  • TVTX $16.48
  • OPRA $18.61
  • Analyst Decision
  • TVTX Strong Buy
  • OPRA Strong Buy
  • Analyst Count
  • TVTX 16
  • OPRA 5
  • Target Price
  • TVTX $33.33
  • OPRA $24.90
  • AVG Volume (30 Days)
  • TVTX 1.5M
  • OPRA 608.7K
  • Earning Date
  • TVTX 07-31-2025
  • OPRA 08-21-2025
  • Dividend Yield
  • TVTX N/A
  • OPRA 4.34%
  • EPS Growth
  • TVTX N/A
  • OPRA N/A
  • EPS
  • TVTX N/A
  • OPRA 0.93
  • Revenue
  • TVTX $273,533,000.00
  • OPRA $521,494,000.00
  • Revenue This Year
  • TVTX $73.84
  • OPRA $22.29
  • Revenue Next Year
  • TVTX $46.72
  • OPRA $15.84
  • P/E Ratio
  • TVTX N/A
  • OPRA $21.20
  • Revenue Growth
  • TVTX 75.65
  • OPRA 26.68
  • 52 Week Low
  • TVTX $7.93
  • OPRA $10.11
  • 52 Week High
  • TVTX $25.29
  • OPRA $22.50
  • Technical
  • Relative Strength Index (RSI)
  • TVTX 59.73
  • OPRA 47.88
  • Support Level
  • TVTX $14.44
  • OPRA $19.05
  • Resistance Level
  • TVTX $16.64
  • OPRA $19.86
  • Average True Range (ATR)
  • TVTX 0.61
  • OPRA 0.69
  • MACD
  • TVTX 0.31
  • OPRA -0.03
  • Stochastic Oscillator
  • TVTX 94.18
  • OPRA 39.64

About TVTX Travere Therapeutics Inc.

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.

About OPRA Opera Limited

Opera Ltd is a world-wide internet brand with a large, engaged, and growing base. It offers users products and services that include a variety of PC and mobile browsers, Opera Gaming portals and development tools, Opera News content recommendation products, and a number of e-commerce products and services. Its browser's features include tabbed browsing, data savings, PC/mobile sync, and numerous features focused on privacy and security, including ad blocking and a built-in VPN. Its browser products include Opera Mini, Opera Browser for Android and iOS, Opera for Computers, Opera GX and Opera GX Mobile, separate browsers tailored for gamers. Geographically, the company generates maximum revenue from the United States, followed by Singapore, Nigeria, Russia, and other locations.

Share on Social Networks: